A Comprehensive Bench-To-Bed Look Into the Application of Gamma-Sterilized 3D-Printed Polycaprolactone/Hydroxyapatite Implants for Craniomaxillofacial Defects, an in Vitro, in Vivo, and Clinical Study Publisher Pubmed



Babaei M¹ ; Ebrahimnajafabadi N¹ ; Mirzadeh M¹ ; Abdali H² ; Farnaghi M¹ ; Gharavi MK² ; Kheradmandfard M³ ; Kharazi AZ¹ ; Poursamar SA^{1, 2} Show Affiliations
Source: Biomaterials Advances Published:2024

Abstract

This study investigates the safety and efficacy of 3D-printed polycaprolactone/hydroxyapatite (PCL/HA) scaffolds for patient-specific cranioplasty surgeries, employing liquid deposition modeling (LDM) technology. This research is pioneering as it explores the impact of gamma radiation on PCL/HA scaffolds and utilizes printing ink with the highest content of HA known in the composite. The mechanical, morphological, and macromolecular stability of the gamma-sterilized scaffolds were verified before implantation. Subsequent research involving animal subjects was conducted to explore the effects of sterilized implants. Eventually, three clinical cases were selected for the implantation studies as part of a phase 1 non-randomized open-label clinical trial. It was shown that a 25 kGy gamma-ray dose for sterilizing the printed implants did not alter the required geometrical precision of the printed implants. The implants exhibited well-distributed HA and strength comparable to cancellous bone. Gamma radiation reduced hydrophobicity and water uptake capacity without inducing pyrogenic or inflammatory responses. Personalized PCL/HA substitutes successfully treated various craniomaxillofacial defects, including trauma-induced facial asymmetry and congenital deformities. HA nanoparticles in the ink stimulated significant osteoconductive responses within three months of implantation. Moreover, the results revealed that while larger implants may exhibit a slower bone formation response in comparison to smaller implants, they generally had an acceptable rate and volume of bone formation. This clinical trial suggests the application of a sterilized PCL/HA composite for craniomaxillofacial surgery is safe and could be considered as a substitute for autologous bone. © 2024